KLK3 and pure red-cell aplasia: Previous studies, including the European Randomised Study of Screening for PrCa clinical trial, suggest that there exists an association between PSA screening and a decreased risk of PrCa mortality,4 which implies a crucial role of PSA in promoting the development and progression of PrCa.3